Skip to the reading
The sermorelin deskQuestions before a sermorelin visit

Weigh the unknowns

What do we know about unwanted effects?

Short studies leave questions about longer use open. Keep the gaps alongside the findings.

The older reports are a starting point

In the older sermorelin research, brief facial flushing and soreness at the injection site were the most commonly reported unwanted effects.

Most of that evidence came from studies in children during the 1990s. There are no up-to-date figures for how often these effects happen in adults using pharmacy-made medicine.

Those reports cannot establish that a medicine offered now will be trouble-free.

Current FDA-reviewed warnings are missing

Throughout this page, FDA means Food and Drug Administration; the initials keep that agency’s name short.

As of September 28, 2026, no sermorelin medicine had current instructions and warnings checked by the FDA.

There is no up-to-date FDA-reviewed list of who must avoid it, how often side effects occur, or what it means during pregnancy.

Growth hormone is a body chemical that helps children grow.

In reviews of related medicines, the FDA raised concerns about high growth hormone levels, including blood sugar changes, fluid build-up, and tumor risks.

The FDA raised these concerns about related drugs. It did not find that sermorelin causes cancer.

Bring pregnancy plans, current health conditions, and all medicines into the personal discussion rather than filling those gaps with an assumption.

Ask for a plan before agreeing

Ask which unwanted effects matter for your situation, what would prompt a review, and who to contact about a problem.

Medicine storage is specific to the product; a blanket rule that every peptide needs refrigeration is wrong.

Ask the pharmacy for written instructions on using, storing, and handling the medicine it would send you.

Know when reading can wait

Severe allergy symptoms can become a life-threatening emergency within a short time.

For severe symptoms, the MedlinePlus guidance calls for emergency help. Trouble breathing and tongue swelling are among the symptoms it names.

For a suspected medicine problem, patients can also make a report through the FDA’s MedWatch program.